dextroamphetamine has been researched along with celecoxib in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 5 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Chang, JK; Chou, CH; Ho, ML; Li, CJ; Wang, GJ | 1 |
Andersen, ML; Dal-Pont, GC; Ferreira, CL; Gava, FF; Quevedo, J; Soares, JC; Tonin, PT; Valvassori, SS; Varela, RB | 1 |
Cararo, JH; Dal-Pont, GC; Garcia, AF; Gava, FF; Menegas, S; Quevedo, J; Soares, JC; Tonin, PT; Valvassori, SS; Varela, RB | 1 |
1 review(s) available for dextroamphetamine and celecoxib
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
4 other study(ies) available for dextroamphetamine and celecoxib
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
The PI3K/Akt/FOXO3a/p27Kip1 signaling contributes to anti-inflammatory drug-suppressed proliferation of human osteoblasts.
Topics: Anti-Inflammatory Agents; Celecoxib; Cell Proliferation; Cells, Cultured; Chromones; Cyclin-Dependent Kinase Inhibitor p27; Dextroamphetamine; Epidermal Growth Factor; Female; Forkhead Box Protein O3; Forkhead Transcription Factors; Gene Expression Regulation; Humans; Indomethacin; Male; Morpholines; Osteoblasts; Phosphatidylinositol 3-Kinases; Phosphorylation; Promoter Regions, Genetic; Proto-Oncogene Proteins c-akt; Pyrazoles; Sulfonamides | 2010 |
Coadministration of lithium and celecoxib attenuates the behavioral alterations and inflammatory processes induced by amphetamine in an animal model of mania.
Topics: Analysis of Variance; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antimanic Agents; Behavior, Animal; Bipolar Disorder; Celecoxib; Corpus Striatum; Cytokines; Dextroamphetamine; Disease Models, Animal; Drug Therapy, Combination; Frontal Lobe; Inflammation; Lithium Compounds; Male; Rats; Rats, Wistar | 2019 |
Coadministration of lithium and celecoxib reverses manic-like behavior and decreases oxidative stress in a dopaminergic model of mania induced in rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antimanic Agents; Behavior, Animal; Bipolar Disorder; Celecoxib; Dextroamphetamine; Disease Models, Animal; Dopamine; Drug Therapy, Combination; Frontal Lobe; Hippocampus; Lithium Compounds; Male; Motor Activity; Oxidative Stress; Rats; Rats, Wistar | 2019 |